Publications by authors named "Charles Rudin"

100Publications

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.

Cell Rep 2020 Dec;33(9):108444

Graduate Program in Pharmacology, Weill Cornell Medicine, New York, NY 10021, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.108444DOI Listing
December 2020

CNS Metastases in Patients With Exon 14-Altered Lung Cancers and Outcomes With Crizotinib.

JCO Precis Oncol 2020 27;4. Epub 2020 Jul 27.

Thoracic Oncology and Early Drug Development Services, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.20.00098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446485PMC
July 2020

Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk.

J Thorac Oncol 2020 Dec 28;15(12):1871-1879. Epub 2020 Aug 28.

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.08.017DOI Listing
December 2020

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.

Front Oncol 2020 7;10:1387. Epub 2020 Aug 7.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.01387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427626PMC
August 2020

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.

Authors:
Ayuko Hoshino Han Sang Kim Linda Bojmar Kofi Ennu Gyan Michele Cioffi Jonathan Hernandez Constantinos P Zambirinis Gonçalo Rodrigues Henrik Molina Søren Heissel Milica Tesic Mark Loïc Steiner Alberto Benito-Martin Serena Lucotti Angela Di Giannatale Katharine Offer Miho Nakajima Caitlin Williams Laura Nogués Fanny A Pelissier Vatter Ayako Hashimoto Alexander E Davies Daniela Freitas Candia M Kenific Yonathan Ararso Weston Buehring Pernille Lauritzen Yusuke Ogitani Kei Sugiura Naoko Takahashi Maša Alečković Kayleen A Bailey Joshua S Jolissant Huajuan Wang Ashton Harris L Miles Schaeffer Guillermo García-Santos Zoe Posner Vinod P Balachandran Yasmin Khakoo G Praveen Raju Avigdor Scherz Irit Sagi Ruth Scherz-Shouval Yosef Yarden Moshe Oren Mahathi Malladi Mary Petriccione Kevin C De Braganca Maria Donzelli Cheryl Fischer Stephanie Vitolano Geraldine P Wright Lee Ganshaw Mariel Marrano Amina Ahmed Joe DeStefano Enrico Danzer Michael H A Roehrl Norman J Lacayo Theresa C Vincent Martin R Weiser Mary S Brady Paul A Meyers Leonard H Wexler Srikanth R Ambati Alexander J Chou Emily K Slotkin Shakeel Modak Stephen S Roberts Ellen M Basu Daniel Diolaiti Benjamin A Krantz Fatima Cardoso Amber L Simpson Michael Berger Charles M Rudin Diane M Simeone Maneesh Jain Cyrus M Ghajar Surinder K Batra Ben Z Stanger Jack Bui Kristy A Brown Vinagolu K Rajasekhar John H Healey Maria de Sousa Kim Kramer Sujit Sheth Jeanine Baisch Virginia Pascual Todd E Heaton Michael P La Quaglia David J Pisapia Robert Schwartz Haiying Zhang Yuan Liu Arti Shukla Laurence Blavier Yves A DeClerck Mark LaBarge Mina J Bissell Thomas C Caffrey Paul M Grandgenett Michael A Hollingsworth Jacqueline Bromberg Bruno Costa-Silva Hector Peinado Yibin Kang Benjamin A Garcia Eileen M O'Reilly David Kelsen Tanya M Trippett David R Jones Irina R Matei William R Jarnagin David Lyden

Cell 2020 Aug 13;182(4):1044-1061.e18. Epub 2020 Aug 13.

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2020.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522766PMC
August 2020

Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.

Clin Cancer Res 2020 Oct 28;26(20):5424-5437. Epub 2020 Jul 28.

MSK-Cornell Center for Translation of Cancer Nanomedicines, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686858PMC
October 2020

Role of mTOR As an Essential Kinase in SCLC.

J Thorac Oncol 2020 Sep 26;15(9):1522-1534. Epub 2020 Jun 26.

Department of Medicine, University of Colorado, Denver, Colorado; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.05.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483946PMC
September 2020

Advances in Small-Cell Lung Cancer (SCLC) Translational Research.

Cold Spring Harb Perspect Med 2020 Jun 8. Epub 2020 Jun 8.

Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/cshperspect.a038240DOI Listing
June 2020

Targeted Therapies and Biomarkers in Small Cell Lung Cancer.

Front Oncol 2020 20;10:741. Epub 2020 May 20.

Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.00741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251180PMC
May 2020

Protein-altering germline mutations implicate novel genes related to lung cancer development.

Authors:
Xuemei Ji Semanti Mukherjee Maria Teresa Landi Yohan Bosse Philippe Joubert Dakai Zhu Ivan Gorlov Xiangjun Xiao Younghun Han Olga Gorlova Rayjean J Hung Yonathan Brhane Robert Carreras-Torres David C Christiani Neil Caporaso Mattias Johansson Geoffrey Liu Stig E Bojesen Loic Le Marchand Demetrios Albanes Heike Bickeböller Melinda C Aldrich William S Bush Adonina Tardon Gad Rennert Chu Chen Jinyoung Byun Konstantin H Dragnev John K Field Lambertus Fa Kiemeney Philip Lazarus Shan Zienolddiny Stephen Lam Matthew B Schabath Angeline S Andrew Pier A Bertazzi Angela C Pesatori Nancy Diao Li Su Lei Song Ruyang Zhang Natasha Leighl Jakob S Johansen Anders Mellemgaard Walid Saliba Christopher Haiman Lynne Wilkens Ana Fernandez-Somoano Guillermo Fernandez-Tardon Erik H F M van der Heijden Jin Hee Kim Michael P A Davies Michael W Marcus Hans Brunnström Jonas Manjer Olle Melander David C Muller Kim Overvad Antonia Trichopoulou Rosario Tumino Gary E Goodman Angela Cox Fiona Taylor Penella Woll Erich Wichmann Thomas Muley Angela Risch Albert Rosenberger Kjell Grankvist Mikael Johansson Frances Shepherd Ming-Sound Tsao Susanne M Arnold Eric B Haura Ciprian Bolca Ivana Holcatova Vladimir Janout Milica Kontic Jolanta Lissowska Anush Mukeria Simona Ognjanovic Tadeusz M Orlowski Ghislaine Scelo Beata Swiatkowska David Zaridze Per Bakke Vidar Skaug Lesley M Butler Kenneth Offit Preethi Srinivasan Chaitanya Bandlamudi Matthew D Hellmann David B Solit Mark E Robson Charles M Rudin Zsofia K Stadler Barry S Taylor Michael F Berger Richard Houlston John McLaughlin Victoria Stevens David C Nickle Ma'en Obeidat Wim Timens María Soler Artigas Sanjay Shete Hermann Brenner Stephen Chanock Paul Brennan James D McKay Christopher I Amos

Nat Commun 2020 05 11;11(1):2220. Epub 2020 May 11.

The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-020-15905-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214407PMC
May 2020

Publisher Correction: Lineage plasticity in cancer: a shared pathway of therapeutic resistance.

Nat Rev Clin Oncol 2020 Jun;17(6):382

Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-020-0355-5DOI Listing
June 2020

Lineage plasticity in cancer: a shared pathway of therapeutic resistance.

Nat Rev Clin Oncol 2020 06 9;17(6):360-371. Epub 2020 Mar 9.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-020-0340-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397755PMC
June 2020

Epigenetic targeting of DNA repair in lung cancer.

Proc Natl Acad Sci U S A 2019 11 29;116(45):22429-22431. Epub 2019 Oct 29.

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1916581116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842636PMC
November 2019

Analyzing the Thin Tail: Searching for Biomarkers of Exceptional Survival in SCLC.

J Thorac Oncol 2019 07;14(7):1122-1124

Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.011DOI Listing
July 2019

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.

J Thorac Oncol 2019 10 19;14(10):1784-1793. Epub 2019 Jun 19.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764905PMC
October 2019

Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived Xenografts.

J Thorac Oncol 2019 10 11;14(10):1743-1752. Epub 2019 Jun 11.

Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764879PMC
October 2019

Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung.

J Thorac Oncol 2019 09 20;14(9):1583-1593. Epub 2019 May 20.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.009DOI Listing
September 2019

Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers.

J Thorac Oncol 2019 05 1;14(5):802-815. Epub 2019 Mar 1.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486868PMC
May 2019

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with -Mutant Lung Cancers.

Clin Cancer Res 2019 02 25;25(3):1063-1069. Epub 2018 Jul 25.

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347551PMC
February 2019

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Cancer Immunol Res 2018 09 10;6(9):1093-1099. Epub 2018 Jul 10.

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0755DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125223PMC
September 2018

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

J Clin Oncol 2018 08 10;36(24):2532-2537. Epub 2018 Jul 10.

Bob T. Li, Ronglai Shen, Darren Buonocore, Zachary T. Olah, Ai Ni, Michelle S. Ginsberg, Gary A. Ulaner, Michael Offin, Daniel Feldman, Helen H. Won, Edyta B. Brzostowski, Gregory J. Riely, David B. Solit, David M. Hyman, Alexander Drilon, Charles M. Rudin, Michael F. Berger, Jose Baselga, Maurizio Scaltriti, Maria E. Arcila, and Mark G. Kris, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Bob T. Li, Nick Pavlakis, and Stephen Clarke, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; and Todd Hembrough, Fabiola Cecchi, and Sarit Schwartz, NantOmics, Rockville, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.9777
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.9777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366814PMC
August 2018

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.

Clin Cancer Res 2018 10 26;24(20):5143-5152. Epub 2018 Jun 26.

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-0401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742772PMC
October 2018

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

J Clin Oncol 2018 08 15;36(23):2386-2394. Epub 2018 Jun 15.

M. Catherine Pietanza, Lee M. Krug, Mark G. Kris, and Charles M. Rudin, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College; Kaitlin M. Woo, Yevgeniva Bensman, Brenda Hurtado, and Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY; Saiama N. Waqar, Washington University School of Medicine in St. Louis, St Louis, MO; Afshin Dowlati, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH; Christine L. Hann, Johns Hopkins University, Baltimore; Alice Chen, National Institutes of Health, Bethesda, MD; Alberto Chiappori, H. Lee Moffitt Cancer Center, Tampa, FL; Taofeek K. Owonikoko, Emory University, Atlanta, GA; and Robert J. Cardnell, Junya Fujimoto, Lihong Long, Lixia Diao, Jing Wang, Patricia de Groot, Erik P. Sulman, Ignacio I. Wistuba, John V. Heymach, and Lauren Averett Byers, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085179PMC
August 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Looking ahead to new therapies in small cell lung cancer.

Authors:
Charles M Rudin

Clin Adv Hematol Oncol 2018 Apr;16(4):269-272

Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
April 2018

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell 2018 05 12;33(5):843-852.e4. Epub 2018 Apr 12.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 885 2(nd) Avenue, New York, NY 10017, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183012
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953836PMC
May 2018

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

J Clin Oncol 2018 03 16;36(7):633-641. Epub 2018 Jan 16.

Hira Rizvi, Francisco Sanchez-Vega, Konnor La, Walid Chatila, Philip Jonsson, Darragh Halpenny, Andrew Plodkowski, Niamh Long, Jennifer L. Sauter, Natasha Rekhtman, Travis Hollmann, Ronglai Shen, Ai Ni, Kathryn C. Arbour, Taha Merghoub, Jedd Wolchok, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Nicholas D. Socci, Michael F. Berger, Barry S. Taylor, Ahmet Zehir, David B. Solit, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Nikolaus Schultz, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Taha Merghoub, Jedd Wolchok, Alexandra Snyder, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Kurt A. Schalper, Yale School of Medicine, New Haven, CT; Justin F. Gainor, Massachusetts General Hospital, Boston, MA; and Alexandra Snyder, Adaptive Biotechnologies, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.3384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075848PMC
March 2018

Small-cell lung cancer in the era of immunotherapy.

Transl Lung Cancer Res 2017 Dec;6(Suppl 1):S67-S70

Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.10.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750148PMC
December 2017

Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers.

Ann Transl Med 2017 Dec;5(23):479

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://atm.amegroups.com/article/view/16865/17870
Publisher Site
http://dx.doi.org/10.21037/atm.2017.09.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733322PMC
December 2017

Atezolizumab for the treatment of non-small cell lung cancer.

Expert Rev Clin Pharmacol 2017 Sep 27;10(9):935-945. Epub 2017 Jul 27.

b Thoracic Oncology Service, Department of Medicine , Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1356717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089509PMC
September 2017

Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus.

J Clin Invest 2017 Aug 26;127(8):2957-2967. Epub 2017 Jun 26.

Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI93472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531414PMC
August 2017

Unravelling the biology of SCLC: implications for therapy.

Nat Rev Clin Oncol 2017 Sep 23;14(9):549-561. Epub 2017 May 23.

Department of Medicine, Memorial Sloan Kettering Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.71DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843484PMC
September 2017

Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses Loss-Driven Tumorigenesis.

Mol Cancer Ther 2017 08 3;16(8):1693-1704. Epub 2017 May 3.

Department of Cancer Biology and David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929164PMC
August 2017

Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA.

J Oncol 2017 14;2017:4517834. Epub 2017 Mar 14.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/4517834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368362PMC
March 2017

Histone Code Aberrancies in Small Cell Lung Cancer.

J Thorac Oncol 2017 04;12(4):599-601

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.008DOI Listing
April 2017

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

Cancer Cell 2017 02;31(2):286-299

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313262PMC
February 2017

The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.

Lung Cancer 2016 12 17;102:21-27. Epub 2016 Oct 17.

Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441998PMC
December 2016

Small-cell lung cancer in 2016: Shining light on novel targets and therapies.

Nat Rev Clin Oncol 2017 Feb 13;14(2):75-76. Epub 2016 Dec 13.

Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; and at the Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.203DOI Listing
February 2017